Percutaneous Treatment of Severe Aortic Regurgitation After Surgical Mitral Valve Repair

Evelina Toscano; Mahmoud Saad Ahmed; Kush P Patel; Thomas Treibel; Simon Kennon; Andreas Baumbach

doi:10.1016/j.jaccas.2023.102131

Percutaneous Treatment of Severe Aortic Regurgitation After Surgical Mitral Valve Repair

JACC Case Rep. 2023 Nov 22:28:102131. doi: 10.1016/j.jaccas.2023.102131. eCollection 2023 Dec 20.

Authors

Evelina Toscano¹, Mahmoud Saad Ahmed^{2

3}, Kush P Patel^{2

3}, Thomas Treibel^{2

3}, Simon Kennon^{2

3}, Andreas Baumbach^{2

4}

Affiliations

¹ Interventional Cardiology Unit, Policlinico di Monza, Monza, Italy.
² Barts Heart Centre, London, United Kingdom.
³ Institute of Cardiovascular Science, University College London, London, United Kingdom.
⁴ Center for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

Abstract

A 54-year-old woman who had recently undergone surgical mitral and tricuspid valve repair was diagnosed with severe aortic regurgitation. She was scheduled for percutaneous treatment and underwent successful transcatheter aortic valve implantation with a 27-mm Trilogy valve (JenaValve Technology). The case documents feasibility of percutaneous treatment in the presence of a mitral ring.

Keywords: aortic valve; cardiovascular disease; imaging; mitral valve; treatment; valve replacement.

Publication types

Case Reports